IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q3 2018 Holdings

Filed 2018-11-07 | 7 holdings | $188.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Surface Oncology IncCOM86877M209$50.8K4,645,45326.9%
Intellia Therapeutics Inc(NTLA)COM45826J105$46.2K1,615,32124.5%
Synlogic IncCOM87166L100$37.7K2,651,96319.9%
Unum Therapeutics IncCOM903214104$34.6K3,361,53518.3%
Spero Therapeutics Inc(SPRO)COM84833T103$14.5K1,376,9687.7%
Carbon Black IncCOM14081R103$3.8K181,2732.0%
Snap Inc(SNAP)CL A83304A106$1.3K150,1600.7%